M&A

LabCorp bags Covance, diversifying into CRO biz with $6.1B buyout
Fierce Biotech
Mon, 11/3/14 - 09:31 am
Covance
LabCorp
M&A
CRO
diagnostics
Bristol-Myers beefs up fibrosis pipeline with $444M option deal
Fierce Biotech
Mon, 11/3/14 - 09:28 am
Bristol-Myers Squibb
Galecto Biotech
Denmark
M&A
IPF
idiopathic pulmonary fibrosis
Pharma's top 10 M&A deals of 2014's first half
Fierce Pharma
Mon, 11/3/14 - 08:57 am
M&A
Actavis
Forest Labs
GSK
Novartis
Bayer
Merck
Mallinckrodt
Questcor Pharmaceuticals
Eli Lilly
Idenix
Nestle
Galderma
Sun Pharma
Ranbaxy
Aptalis
Abbott Labs
CFR
AbbVie CEO: Unlikely to Pursue Another $50 Billion Deal
WSJ Online
Fri, 10/31/14 - 02:02 pm
AbbVie
M&A
Rick Gonzalez
Avanir Inroads in Alzheimer’s Justify Offers: Real M&A
Bloomberg
Thu, 10/30/14 - 12:22 pm
M&A
Avanir
Alzheimer's disease
Lundbeck
Eli Lilly
Mallinckrodt
Shire
Perrigo Said in Exclusive Talks to Acquire Omega Pharma
Bloomberg/Businessweek
Thu, 10/30/14 - 12:13 pm
Perrigo
Omega Pharma
M&A
Abbott buys into electrophysiology with $250m Topera acquisition
Mass Device
Wed, 10/29/14 - 11:52 am
Abbott Labs
electrophysiology
Topera
M&A
devices
U.S. law firm says investigating AbbVie over collapsed Shire deal
Yahoo/Reuters
Wed, 10/29/14 - 10:13 am
AbbVie
Shire
M&A
New Tax Rules Won’t Stop Pfizer From Bidding U.S. Goodbye
Bloomberg
Wed, 10/29/14 - 09:14 am
Pfizer
tax inversions
M&A
Ackman-Allergan Enters Courtroom Phase: Opening Line
Bloomberg
Tue, 10/28/14 - 06:51 pm
Bill Ackman
Allergan
Valeant Pharmaceuticals
M&A
Ackman’s $5.3 Billion Allergan Bet Examined Before Vote
Bloomberg
Tue, 10/28/14 - 08:58 am
Bill Ackman
Allergan
Valeant Pharmaceuticals
M&A
Dealpolitik: Path to Nowhere in Allergan Litigation?
WSJ Online
Mon, 10/27/14 - 03:29 pm
Allergan
M&A
Valeant Pharmaceuticals
Allergan Comments on Valeant's Potential Increased Offer
Yahoo
Mon, 10/27/14 - 09:28 am
Allergan
Valeant Pharmaceuticals
M&A
Zogenix Acquires U.K.-Based Brabant Pharma
Yahoo
Mon, 10/27/14 - 07:35 am
Zogenix
UK
Brabant Pharma
M&A
Valeant says ready to raise Allergan bid to at least $200/share
Yahoo/Reuters
Mon, 10/27/14 - 07:32 am
Valeant Pharmaceuticals
Allergan
M&A
Shire’s Got Big Plans for AbbVie’s Breakup Fee
WSJ Online
Fri, 10/24/14 - 07:05 pm
AbbVie
Shire
M&A
Allergan
Pfizer stock buyback dims prospects of AstraZeneca bid
Seeking Alpha
Fri, 10/24/14 - 08:04 am
Pfizer
AstraZeneca
M&A
stock buyback
Actavis CEO Saunders Has $70 Billion in Deals to Choose From
Bloomberg
Fri, 10/24/14 - 08:02 am
Actavis
M&A
Brent Saunders
Allergan
Pfizer
Omega Pharma
Salix
The Mylan-Abbott Inversion Deal is Still on… but With Some Changes
WSJ Pharmalot
Wed, 10/22/14 - 07:14 pm
Mylan Labs
Abbott Labs
M&A
tax inversions
AbbVie finally admits it was trying to dodge U.S. taxes
Fortune
Wed, 10/22/14 - 06:57 pm
AbbVie
Shire
tax inversions
M&A

Pages